Back
Immunovant Stock Predictions
![](/images/offers/ims/large/offer2.jpg)
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.
Sell
45
IMVT
Immunovant
Last Price:
29.10
Seasonality Move:
45.33%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer4.jpg)
$1,300 into $45,000 in just 4 MONTHS?!
See here to see the full details.Immunovant Stock Forecast
- Over the next 52 weeks, Immunovant has on average historically risen by 93.7% based on the past 5 years of stock performance.
- Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Immunovant Stock Undervalued?
The current Immunovant [IMVT] share price is $27.80. The Score for IMVT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. - IMVT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Immunovant Stock Go Up Next Year?
- Over the next 52 weeks, Immunovant has on average historically risen by 93.7% based on the past 5 years of stock performance.
Immunovant Stock Rating
Sell
45
Immunovant (IMVT)
is a Sell
Is Immunovant overpriced?
- Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Immunovant Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com
52-Week Data
52-Week High:
45.58
52-Week Low:
18.82
Prediction Charts
Market Cap:
4.06B
Price in USD:
27.80
Volume:
1.63M
Beta:
0.72
Technical Analysis
SMA50:
27.85
SMA100:
29.15
SMA200:
33.38
52-Wk Change:
27.82%
Stock Predictions
-
Is Immunovant stock public?
Yes, Immunovant is a publicly traded company. -
What is the Immunovant stock quote today?
The Immunovant stock price is 27.80 USD today. -
How to buy Immunovant stock online?
You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jul-8 | 27.12 | 27.65 | 27.84 | 26.74 |
Jul-9 | 27.57 | 29.70 | 29.71 | 27.43 |
Jul-10 | 30.10 | 30.35 | 30.48 | 29.65 |
Jul-11 | 30.89 | 30.34 | 32.00 | 29.97 |
Jul-12 | 30.88 | 30.57 | 30.88 | 30.03 |
Jul-15 | 30.77 | 30.51 | 31.07 | 30.07 |
Jul-16 | 30.82 | 30.92 | 31.36 | 30.28 |
Jul-17 | 30.49 | 29.98 | 30.86 | 29.30 |
Jul-18 | 29.95 | 28.41 | 29.95 | 28.06 |
Jul-19 | 28.47 | 27.97 | 28.88 | 27.78 |
Jul-22 | 28.19 | 28.00 | 28.81 | 27.78 |
Jul-23 | 27.81 | 27.99 | 28.34 | 26.50 |
Jul-24 | 27.97 | 27.94 | 28.61 | 27.28 |
Jul-25 | 28.13 | 27.80 | 28.50 | 27.37 |
Immunovant Earnings
Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.
Immunovant Forecast Revenue Growth
Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.34 per share.
* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.